Apyx Medical (APYX) Receivables - Other (2018 - 2023)

Apyx Medical (APYX) has reported Receivables - Other for 6 consecutive years, with $100000.0 the latest figure, recorded in Q4 2023.

• For the quarter ending Q4 2023, Receivables - Other changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2023 stood at $100000.0 (changed 0.0% YoY), and the FY2023 full-year result was $100000.0, changed 0.0% from the prior year.
• Receivables - Other fell to $100000.0 in Q4 2023 per APYX's latest filing, from $596000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $1.7 million in Q2 2020 and bottomed at $19000.0 in Q3 2022.
• Historically, Receivables - Other has averaged $728222.2 across 5 years, with a median of $734500.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other slumped 97.82% in 2022, then jumped 3036.84% in 2023.
• Over 5 years, Receivables - Other stood at $1.2 million in 2019, then gained by 3.41% to $1.3 million in 2020, then tumbled by 62.12% to $483000.0 in 2021, then slumped by 79.3% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
• According to Business Quant data, Receivables - Other over the past three periods registered $100000.0, $596000.0, and $315000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.